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Abstract
Genomic medicine is transforming patient care. However, the speed of development has left a 
knowledge gap between discovery and effective implementation into clinical practice. Since 2010, 
the Training Residents in Genomics (TRIG) Working Group has found success in building a 
rigorous genomics curriculum with implementation tools aimed at pathology residents in 
postgraduate training years 1–4. Based on the TRIG model, the interprofessional Undergraduate 
Training in Genomics (UTRIG) Working Group was formed. Under the aegis of the 
Undergraduate Medical Educators Section of the Association of Pathology Chairs and 
representation from nine additional professional societies, UTRIG’s collaborative goal is building 
medical student genomic literacy through development of a ready-to-use genomics curriculum. 
Key elements to the UTRIG curriculum are expert consensus-driven objectives, active learning 
methods, rigorous assessment and integration.
Keywords
active learning; curricula; genetics; genomics; interprofessional; medical education; NCI; 
precision medicine
Precision medicine has great potential for improving patient care; however, the incredible 
speed upon which it is being developed has left a knowledge gap between discovery and 
effective implementation of those discoveries into clinical practice. The goal of the 
Undergraduate Training in Genomics (UTRIG) Working Group is, using a collaborative and 
interprofessional approach, the development of nationally available resources to assist 
medical school educators in closing this gap.
The genomic medicine era
With the completion of the human genome project, precision medicine has transformed 
medical practice. Oncology is a specialty that has been quick to embrace the genomic 
medicine approach with oncologists routinely ordering tumor sequencing assays that analyze 
multiple genes in order to identify options for personalized treatment. In a 2014 study of 
1007 patients with lung cancer, the use of a ten-gene panel of oncogenic drivers allowed 
28% to be treated with targeted therapy. These patients survived a median of 3.5 years 
compared with 2.4 years for those who did not receive targeted treatment [1]. In a 2015 
study of 102 children with refractory cancer, whole exome and transcriptome analysis led to 
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treatment modification in 14 patients with nine having ongoing partial or complete clinical 
remissions [2]. This emerging approach in oncology calls into question the current use of 
diagnostic classification systems of tumors. For example, in a patient with an unknown 
primary tumor presenting in the liver, the genetic profile of the tumor and the potential 
identification of precision medicine chemotherapeutic targets may be clinically more 
important than the primary location of the tumor. As stated by Dr Douglas Lowy and Dr 
Francis Collins in a New England Journal of Medicine perspective regarding the United 
States Cancer Moonshot Task Force, “cancer is a disease of the genome” [3].
The potential for personalized treatment extends to many fields in medicine. 
Pharmacogenomics allows physicians to customize treatment with medications including 
antiplatelet and antiviral agents. The need and potential for these tailored treatments is clear. 
A 2001 study addressing the clinical application of pharmacogenetics showed striking 
percentages of patients for whom drugs are ineffective ranging from 48% (migraine 
pharmacology) to 75% (oncology pharmacology) [4].
Genomic testing also improves diagnostics. Next-generation sequencing based assays allows 
for preconception carrier screening for over 100 genetic diseases. In infectious disease, 
genomic sequencing techniques can be important diagnostic tools when traditional methods 
have failed. In the case of a child with chronic meningitis, next-generation sequencing of 
cerebrospinal fluid led to the diagnosis of leptospirosis when culture had been negative [5]. 
Genomic testing has also proven clinically useful in the setting of rare diseases. In the case 
of a child with intractable inflammatory bowel disease, whole-exome sequencing led to the 
identification of a variant causing hemophagocytic lymphohistiocytosis (HLH). The patient 
received a bone marrow transplant to treat HLH that also cured his inflammatory bowel 
disease [6]. In a study of 250 patients with rare diseases, 62 had the molecular cause 
determined through whole-exome analysis. Demonstrating the rapid acquisition of genomic 
data, approximately 25% of the diagnoses were based on disease-gene discoveries made 
within the past 2 years prior to the study [7].
Given the clinical importance of genomic testing in clinical practice, it is not surprising that 
funding is being directed for the purposes of improving genomic data sharing and 
developing novel genomic assays. The Precision Medicine Initiative announced by President 
Obama in 2015 demonstrated further recognition of the importance of genomics-based 
oncology practice with $70 million earmarked for detection of genetic cancer drivers [8]. 
Consequently, there has been a surge in precision-driven initiatives and centers to research 
and implement these ground-breaking approaches to patient care.
Knowledge gap
Over the last two decades, research elucidating the human genome and its potential 
application has grown exponentially. However, the speed at which this has occurred has left 
a wide knowledge gap between discovery and implementation of those discoveries into 
clinical practice. As genomics enters mainstream clinical practice, physicians without 
specialized training in genetics/genomics potentially face uncertainty in ordering and 
interpreting genomic testing [9–13] and therefore leading to both under- and overutilization 
of genomics-based diagnostic tests. A number of studies have shown that genetic counselor 
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screening of molecular genetic testing orders led to revision of a remarkable 8–26% of 
orders [14,15]. In many cases, the tests were cancelled due to inappropriate ordering caused 
by a lack of physician comprehension of genetic testing. The cancellation of these tests 
prevented a waste of resources as well as potential patient distress over genetic variants of 
uncertain significance.
Physicians admit to this knowledge gap. In a recent survey of internists at two academic 
medical centers, 74% self-rated their genetics knowledge as very/somewhat poor and 
approximately 80% indicated a need for additional training. In spite of their acknowledged 
lack of training, 65% of these physicians had counseled a patient on a genetic issue and 44% 
had ordered a genetic test in the previous 6 months [16]. Similar results have been reported 
for psychiatrists and neurologists. In other studies, only approximately 15% of primary care 
physicians feel comfortable ordering genomic tests or explaining them to their patients 
[17,18]. In regard to pharmacogenomics, a nationwide survey of US physicians in 2012 
explored awareness, utilization and competency in this area. While 98% of the 10,000 
responding physicians agreed that genetic variations may influence drug response, only 10% 
felt adequately informed about pharmacogenomics testing [19]. In another study of 401 
family doctors, 55% reported they had no knowledge of the Genetic Information and Non-
Discrimination Act, which impacts potential discrimination in insurance and employment 
for patients undergoing genetic testing [20]. Although understanding the nuances of genetic 
and genomic testing in terms of clinical and personal issues is critical to the patients, it 
cannot be addressed by referral to specialists alone as there is a shortage of genetics 
specialists in the healthcare workforce [21]. Therefore, improving the genomic literacy of 
providers across specialties is a critical goal for effective implementation of approaches in 
genomic medicine.
Efforts to improve physician genomics knowledge
Recognizing the need to improve healthcare practitioner knowledge, there have been a 
number of genomics education initiatives. In 2013, the National Human Genome Research 
Institute assembled the Inter-Society Coordinating Committee for Practitioner Education in 
Genomics (ISCC) from 23 professional societies, 15 institutes at the NIH and organizations 
interested in physician education. The mission of the ISCC is to develop and share best 
practices for improving the genomic literacy of providers. In April 2014, the ISCC published 
a white paper entitled ‘Framework for Development of Physician Competencies in Genomic 
Medicine’ in Genetics in Medicine. This framework defined five entrustable professional 
activities specifically in genomics, each with integrated core competencies based on the 
Accreditation Council of Graduate Medical Education’s six core competencies [22].
Specialists in genomic medicine include medical geneticists, genetic counselors and 
molecular genetic pathologists. For individuals enrolled in medical genetics residency 
programs, there is a comprehensive graduate medical curriculum covering the full range of 
topics pertaining to clinical genetics, from culturally competent communication to single 
gene and genome-wide genetic testing strategies [23]. Pathologists have a unique role in 
genomic testing. Not only do they assist in directing genetic testing laboratories but they 
play an important role in selecting tumor and other diseased tissue for analysis and 
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integrating molecular findings into histopathology reports. As such, it makes sense that 
pathologists are also leaders in genomics education. In 2015, a College of American 
Pathologists work group published a list of 32 high-priority genomics competencies for 
practicing pathologists [24]. In 2016, to provide a framework for pathology resident 
education in molecular genetics and genomics, the Association for Molecular Pathology 
released ‘A Suggested Molecular Pathology Curriculum for Residents’ [25]. This document 
provides specific objectives related to all aspects of molecular pathology including genomic 
technology and informatics. The objectives are divided into ‘prerequisites’, ‘required’ and 
‘recommended’ categories. However, although these above documents are valuable 
resources for guiding content for resident education, they do not provide tools for 
implementation of a comprehensive curriculum.
The Training Residents in Genomics (TRIG) Working Group, formed in 2010 through the 
Pathology Residency Directors Section (PRODS) of the Association of Pathology Chairs 
(APC), has found success in building a rigorous genomic curriculum with tools for 
implementation aimed at Postgraduate Year (PGY) 1–4 resident level trainees [26]. 
Recognizing that education necessitates a collaborative approach, the working group has 
representatives from several major pathology organizations, the National Society of Genetic 
Counselors and the American College of Medical Genetics and Genomics. Developed with 
the support of an R25 grant from the National Cancer Institute, the curriculum includes four 
exercises following a breast cancer patient through different levels of genetic testing: single-
gene testing; prognostic gene panels; cancer gene panels; and whole-exome sequencing. 
Based on this curriculum, the group has held over 20 genomics workshops for residents and 
practicing physicians using a team-based learning (TBL) approach. The workshops have 
been highly reviewed with 97% of participants stating they would recommend the session to 
their colleagues. As one of the first examples of TBL at a national meeting, the workshop 
design process and assessment have been published as an educational innovation [27].
The TRIG group has also developed a train-the-trainer handbook and toolkit designed to 
help others implement local teaching sessions [28]. The handbook contains workshop 
questions and answers, detailed information on teaching using a variation of the TBL format 
and a preparation checklist with tips on implementation. The toolkit contains all of the 
necessary handouts and PowerPoint lectures. To ensure the best possible product, all 
materials underwent outside peer-review by a group of pathologists and genetic counselors. 
Online modules that translate the workshop experience to a virtual environment, including 
simulation-based learning of online genomics tools, have also been released on the TRIG 
website (http://pathologylearning.org/trig). Since the materials were made available in 2014, 
over 1250 individuals from 60 different countries have registered to download the material. 
Respondents to a 2016 downloader survey reported using at least some portion of the 
materials with 776 medical students, 214 residents, 76 fellows and 60 laboratory 
technologists. Similar evidence of utility was seen in a 2016 PRODS survey; of the 52 
respondents (37% of US programs), 32% are using at least some component of the TRIG 
curriculum.
Demonstrating adaptability of the TRIG model, in 2017, through the ISCC, specialty-
agnostic universal modules have been released based on the TRIG approach. With these 
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‘plug and play’ exercises, genes and diseases can be tailored to provide specialty-specific 
education. Workshops based on these modules have been held at the American Academy of 
Neurology, American Heart Association and American Academy of Ophthalmology annual 
meetings.
TBL, problem-based learning, patient simulation, flipped classroom activities and case 
discussions are all forms of active learning [29]. Active learning distinguishes itself from the 
traditional lecture by promoting student engagement in the learning process rather than 
passively receiving information [30]. Compared with the traditional lecture format of 
information delivery, active learning has been shown by Freeman et al. to significantly 
increase student performance in science, technology, engineering and mathematics (STEM) 
disciplines [31]. Their meta-analysis of 225 studies that reported data on examination scores 
or failure rates revealed that active learning in college STEM courses, when compared with 
traditional learning, increased examination performance (raising average grades by half a 
letter). They also found that failure rates under traditional lecturing were 55% higher than 
those documented with active learning. Based on their results, the authors called for the 
abandonment of traditional lectures in favor of active learning in STEM courses stating that 
“if the experiments analyzed here had been conducted as randomized controlled trials of 
medical interventions, they may have been stopped for benefit… because the treatment 
being tested was clearly more beneficial.” In addition, there is growing evidence that active 
learning approaches can significantly improve learning for some subgroups of learners, 
especially women [32,33] and students from disadvantaged educational and socioeconomic 
backgrounds [34]. Given the success of TRIG and other existing data, active learning 
approaches should be particularly emphasized for genomics education.
Medical student training in genomics
Given the aforementioned knowledge gap in genomics among practicing physicians, it is not 
surprising that experts agree upon the importance of physician training in the effective 
practice of genomic medicine [21,22,35,36]. This consensus applies not only to practicing 
healthcare providers, but also to future physicians. Thus, introducing these concepts 
beginning in medical school can provide the foundation upon which a continuously 
expanding amount of information can be built. In addition, early exposure would allow 
medical students to consider a career related to genomics. Although within US and Canadian 
medical schools there is a trend toward increasing genetics and genomics education, a recent 
survey-based study found that 40% of genetics course directors still do not cover key 
emerging genomic medicine topics in their curriculum [37]. In addition, this study found 
that the overwhelming majority of taught genetics content is presented in preclinical 
coursework. This approach misses the opportunity to apply these concepts during the 
clinical phase of education where real patient cases demand an understanding of targeted 
therapies, the ability to appropriately order genomic tests and effectively explain test results 
to patients.
In a pilot study conducted at the Larner College of Medicine at the University of Vermont 
(VT, USA), a National Board of Medical Examiners (NBME)-customized assessment tool 
was designed and implemented to test students’ performance in six distinct areas of genetics 
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and genomics to compare performance with national averages. This exam was 
complemented with a student self-assessment specifically addressing 25 integrated core 
competencies in genomic medicine selected for appropriate training level from the ISCC 
framework (Table 1) [22]. All class of 2017 students in their final month of the preclinical 
curriculum were invited to participate; 71 students (63% of the class) completed the exam 
and 66 completed the self-assessment. Analysis of exam performance and self-assessment 
revealed gaps within the curriculum including molecular techniques, mutations and cancer, 
online genetics resources, multifactorial conditions, microbial genomic testing and 
interpretation of genomic test results. The data from this pilot study served as the framework 
for the funded development of a genetics/genomics curriculum focused on active learning at 
the Larner College of Medicine.
The Association for Professors of Human and Medical Genetics (APHMG) has published a 
list of genetics competencies for medical students [38]. In addition, the Undergraduate 
Medical Educators Section (UMEDS) of the APC has developed and published the 
Pathology Competencies for Medical Education which includes the topic of genetic 
mechanisms (Disease Mechanisms and Processes Competency) and genomics (Diagnostic 
Medicine and Therapeutic Pathology Competency) [39 ]. Examples of primarily local 
medical student genomics curricula and teaching materials are also available on 
MedEdPORTAL.org and in the Genetics Education Resource Exchange (available to 
APHMG member institutions). There are, however, few rigorously vetted national resources 
to assist medical school course directors in teaching genomic medicine.
To assess the need for educational tools, in August 2016, a survey was conducted through 
the UMEDS of APC. Pathologists play a major role in medical student education and 
UMEDS members represent course directors, responsible for overseeing course content, 
from 115 American medical schools. Of the 32 respondents, 94% believed genomic 
medicine was an important curricular topic for medical students yet only 12 of 28 (42%) 
reported a local curriculum in genomic medicine. It is not surprising then that nearly all 
respondents (25 of 28, 89%), believed there was a need for nationally available educational 
tools to assist in teaching medical students genomic medicine. To fill this need, the UTRIG 
Working Group was established in 2016. The UTRIG Working Group is under the aegis of 
UMEDS and made up of pathology course directors, genetics experts and medical students. 
As with TRIG, UTRIG demonstrates a collaborative approach across specialties (Box 1).
Box 1
Undergraduate Training in Genomics cooperating organizations
• AACC, ACLPS, ACMG, AMP, APC, APHMG, ASCP, ASIP, Barts and the 
London School of Medicine and Dentistry, ICPI and NSGC
AACC: American Association for Clinical Chemistry; ACLPS: Academy of 
Clinical Laboratory Physicians and Scientists; ACMG: American College of 
Medical Genetics and Genomics; AMP: Association for Molecular Pathology; 
APC: Association of Pathology Chairs; APHMG: Association of Professors 
of Human and Medical Genetics; ASCP: American Society for Clinical 
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Pathology; ASIP: American Society for Investigative Pathology; ICPI: 
Intersociety Council for Pathology Information; NSGC: National Society of 
Genetic Counselors.
UTRIG curriculum: key elements of development & implementation
Applying the TRIG model to undergraduate medical education will lead to increased faculty 
confidence in teaching genetics/genomics material as well as establishing uniform 
implementation across medical schools. The goal of UTRIG is to promote strong, 
standardized integration of genetics/genomics education into medical school curricula to 
prepare future physicians to practice in the age of precision medicine and empower them to 
teach those already in practice. The successful development of the UTRIG curriculum is 
based on four key elements: achieving expert consensus on goals and objectives; embracing 
active learning methods; rigorous assessment; and effective integration into existing 
curricula.
Achieving consensus
Although aligned by a common goal, the UTRIG Working Group is diverse in its areas of 
expertise which include laboratory medicine, surgical pathology, molecular pathology, 
genetics, informatics, genetic counseling, administration and education. By employing a 
consensus-building process, the input of this panel of experts can be maximally leveraged to 
support curricular goals and objectives. Given the vetting and implementation of the TRIG 
curriculum, the UTRIG Working Group used the TRIG exercises as a starting point. The 
TRIG handbook and toolkit were distributed to the UTRIG members along with a 
comprehensive survey. Members were asked to comment on the utility of specific TRIG 
components for medical school education including learning objectives, case descriptions, 
online genomics tools and questions. All 11 respondents agreed that the TRIG material 
could be adapted to medical students. Comments have been collated for distribution back to 
the working group with ongoing team discussion to develop a student curriculum.
Active learning
As the evidence of benefit builds, curricula across US medical schools are shifting away 
from traditional lectures toward active learning modalities [40–43]. Active learning, with its 
focus on interaction, is particularly suited to deep learning of complex genetics and genomic 
content including the ethical issues involved in genetic testing and the effective application 
of online genomics tools to clinical analyses. A study of the effects of adding short online 
lecture content on genetics to free up class time for in-class activities in a university biology 
course showed that students retained information better and scored higher on exams while 
faculty had more in-class time to interact with the students [44].
Although recently established medical schools have leaned toward lecture-free curricula for 
the reasons stated above, the adoption of active learning educational methods in more 
established schools has not been without barriers. Reported faculty barriers to adoption 
include lack of necessary class time, a high comfort level with traditional lectures, 
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insufficient time to develop active learning materials and lack of control of the classroom 
[45,46]. Active learning methods have been shown to increase engagement, higher order 
learning and learning outcomes compared with the traditional lecture; however, it also 
decreases the amount of information delivery. Increasing pressure to cover foundational 
science content in shorter periods of the medical curriculum, as well of a lack of faculty 
protected time needed to develop strong active learning material, can potentiate conflict 
between active learning methods and traditional curricular frameworks. Furthermore, the 
topic of genomic medicine is out of the comfort zone of many course directors. The solution 
to these challenge lie in building targeted, multidisciplinary online education modules along 
with faculty handbooks that outline teaching best practices for each active in-class session. 
Moreover, this model lends itself well to implementation in the clinical years, a segment of 
the medical curriculum that is in need of further exposure to genetics [37] and that must 
adapt to students being assigned to disparate clinical training sites. As with the TRIG 
curriculum, UTRIG plans to create a genomics curriculum library of ready-to-use learning 
tools and faculty manuals to convert barriers into welcome additions.
Assessment
The TRIG Working Group utilized surveys and exams to determine curriculum efficacy. The 
Resident In-Service Exam (RISE), taken by every PGY1–4 pathology resident in the USA, 
has also provided valuable data. Since 2013, survey and knowledge questions related to 
genomic medicine have been included in the RISE [47] and a significant increase in targeted 
resident training in genomics has been observed. Of note, from an initial 2010 PRODS 
survey suggesting only 30% of residency programs provided training in genomic medicine, 
the result has now climbed to approximately 80% based on response for the 2017 RISE. The 
RISE survey and knowledge questions created by the TRIG Working Group have provided 
valuable data on the degree and efficacy of resident training in genomic pathology on a 
national scale. There are few published examples of the use of an assessment tool with the 
scope of the RISE to study curricular improvement.
Similar to TRIG, the UTRIG Working Group also plans a rigorous assessment of the 
curriculum and educational tools. The RISE-FIRST is an exam taken by over 60% of the 
first-year pathology residents approximately 1 month into their training. UTRIG will use this 
tool to assess, albeit on a smaller scale than the RISE, medical school genomics education. 
Since 2015, survey questions have been included on the RISE-FIRST and the data indicate 
students have less comfort with genomics concepts when directly compared with other areas 
of medicine (e.g., interpreting glucose test results). Importantly, the performance of PGY1 
pathology residents on this assessment is likely an overestimate of genomics literacy 
compared with medical students who chose other specialties that might have less focus on 
genetics and genomics. Other question responses suggest a need for increased interaction 
with genetic counselors and medical geneticists during medical school to help develop a 
better appreciation of the application of genetics to clinical care. Moreover, the genetics 
content on the NBME shelf examinations is a minor component of the overall examination, 
and genomics is not listed among the topics in the NBME content outline [48]. As such, 
students in specialties with reduced focus on genetics may enter residencies with diminished 
understanding of genetics and genomics principles after limited assessment of the topics on 
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licensing examinations and virtually no contact with the discipline in their clinical years. 
The RISE-FIRST data will serve as a baseline with continued assessment as the UTRIG 
curricular material becomes available. The Association of American Medical Colleges 
(AAMC) curriculum inventory content report may also be a mechanism to obtain baseline 
data in regard to whether and how schools currently report teaching of genomics and 
whether this changes with dissemination of UTRIG educational tools.
Integration
With the rise of precision medicine, clinicians trained in genetics and genomics will be best 
positioned to care for patients and strengthen physician–patient trust by making informed 
decisions in the utilization of technologies for personalized risk assessment, diagnosis, as 
well as treatment selection, dosing and monitoring. A pragmatic approach with clinical 
integration is critical to the success of establishing this level of genetics/genomics 
knowledge. Just as physicians do not need to fully understand the physics of magnetism to 
make use of an MRI, physicians need not have advanced and in-depth education in genomic 
sequencing to make effective clinical use of this technology. Integration of genomics into 
medical education may have the additive benefit of promoting interest in medical genetics or 
molecular pathology as a specialty; however, the overall goal should be focused on 
graduating genomic-literate physicians in all specialties. The UTRIG plan is not to introduce 
genomics as a standalone topic, but rather to integrate it with relevant topics in the 
preclinical years to highlight clinical relevance and link to specific patient scenarios in the 
clinical years (e.g., the use of next-generation sequencing in determining cancer treatment 
options or requiring students to produce a three generation family tree with a standardized 
patient while learning about breast cancer and founder mutations). Early exploration is key 
to dissipating fear of the material and the use of standardized patients and clinical skill 
exams are excellent means to foster the development of informed physicians and enhancing 
patient-care skills around genetics and genomics.
To best integrate the curriculum, there is also a need to build not only student but faculty 
comfort with genomics concepts. In the aforementioned survey of medical school course 
directors, although there was a strong movement toward integrated curricula, a high 
percentage of the course directors overseeing the genetics content were nongeneticists [37]. 
This gets to the very core of the knowledge gap challenge. When education leaders 
themselves do not feel genomically literate, the chasm expands. As with TRIG and planned 
for UTRIG, the solution lies in standardized, vetted education material with faculty manuals 
that close this knowledge gap. Therefore, parallel to the development of the UTRIG 
educational tools are the building of faculty manuals and a roadmap for implementation.
Conclusion
There is clearly a need for increased physician training in genomic medicine. There has been 
some success, particularly for pathology residents (through materials created by the TRIG 
Working Group as well as adaptation to some specialties outside of pathology) and for 
medical students (through materials collected and developed by the APHMG). Genomics 
education, however, remains an area that needs further attention in medical school curricula, 
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particularly in terms of genomic analysis and applied settings directly connected to clinical 
cases in order to lay the framework for this critical knowledge for all physicians. Building 
on TRIG and with continued funding through the National Cancer Institute, the UTRIG 
Working Group plans to take a similar approach to undergraduate medical education. 
Membership includes a diverse group of medical educators, genetics professionals and 
medical students. There is also a clear plan to obtain expert consensus on a set of active-
learning-based teaching sessions with assessment and integration into existing medical 
student curricula. It is our goal to provide tools that can be integrated into medical curricula 
even by nonspecialists to increase the genomic literacy of our future physicians, a critical 
step to ensuring these powerful approaches continue to make inroads into patient care.
Future perspective
The TRIG/UTRIG Working Group model represents only one approach to closing the 
knowledge gap in genomics education. Additional tools are needed to help facilitate training 
not only of physicians but also nurses, physician assistants and others for which an 
understanding of genomics will improve patient care. It is hoped that funding organizations 
will also consider greater financial support for educating health professionals in genomic 
medicine. While projects such as the ‘Cancer Moonshot’ are critical in applying genomic 
medicine to the clinic, there will be difficulty with such translation without resources 
allocated to improving practitioner education. Furthermore, to truly encourage integration of 
genomics curricula into training programs, the Accreditation Council of Graduate Medical 
Education and Liaison Committee on Medical Education should consider developing 
genomics-specific requirements and competencies. As licensing and board certification 
exams drive learning, these should also include genomics-related questions. Lastly, as exams 
typically test knowledge acquisition, development of evaluation tools that directly measure 
skill-based objectives, such as effective provider–patient communication, are critical for 
determining if educational programs are having the desired effect.
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Executive summary
The genomic medicine era
• Precision medicine has great potential for improving patient care; however, 
the incredible speed upon which it is being developed has left a knowledge 
gap between discovery and effective implementation of those discoveries into 
clinical practice.
• Survey studies have shown that physicians openly admit this knowledge gap, 
self-rating their genomics knowledge base as low with acknowledgment of 
the need for additional training, despite the fact that ordering, interpreting and 
explaining genomic test results to their patients have entered mainstream 
medical practice.
Efforts to improve health practitioners’ genomics knowledge
• Important initiatives to improve health practitioner genomics education 
include the Inter-Society Coordinating Committee for Physician Education in 
Genomics white paper entitled ‘Framework for Development of Physician 
Competencies in Genomic Medicine’, the College of American Pathologists 
Genomics Curriculum Work Group’s 32 high-priority genomics 
‘Competencies for Practicing Pathologists’, the Association for Molecular 
Pathologists ‘A Suggested Molecular Pathology Curriculum for Residents’ 
and the Association for Professors of Human and Medical Genetics ‘Medical 
School Core Curriculum in Genetics’.
• The Training Residents in Genomics (TRIG) Working group, formed in 2010 
through the Pathology Residency Directors Section of the Association of 
Pathology Chairs and supported by an R25 grant from the National Cancer 
Institute, has successfully built a rigorous genomics curriculum with tools for 
implementation aimed at resident level trainees.
• To close the knowledge gap it is necessary to start at the beginning. Building 
genomic literacy in our medical students is critical to not only preparing of 
future physicians to practice in the age of precision medicine but to empower 
them to teach those already in practice.
• The Undergraduate Training in Genomics (UTRIG) Working Group, 
organized in 2016 under the aegis of the Undergraduate Medical Educators 
Section of the Association of Pathology Chairs, is an interprofessional 
working group with a collaborative goal of building genomic literacy in 
medical students through the development of a standardized, ready-to-use 
genomics curriculum.
UTRIG curriculum: key elements of development & implementation
• Consensus: employing a consensus-building process, the input of a team of 
interprofessional experts can be maximally leveraged to support curricular 
goals and objectives.
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• Active learning (AL): as the evidence of benefit builds, US medical schools 
are shifting away from traditional lectures toward AL. AL modalities are 
particularly suited to complex genetics/genomics content such as ethical 
issues and the effective application of online genomic tools. UTRIG plans to 
create a genomic curriculum library of learning tools and faculty manuals for 
ready-to-use AL sessions.
• Assessment: rigorous assessment of the curriculum and educational tools is 
essential to providing a standardized product and for continuous 
improvement. On a national level, the RISE-FIRST exam, taken by first year 
pathology residents, will allow assessment of medical school genomics 
education.
• Integration: a pragmatic approach to this curriculum with clinical integration 
is key to its success. Although there may emerge an additive benefit of 
promoting interest in a career in medical genetics or molecular pathology, the 
overall goal of this curriculum is graduating genomic-literate physicians in all 
specialties.
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Table 1
Students were asked to indicate their level of confidence in their ability to do each of 25 selected ISCC-
integrated core competencies in genomic medicine.
Competency Average confidence†
Use online genetics-specific resource 2.25 ± 0.15
Use empirical risk figures to provide information for multifactorial conditions 2.37 ± 0.13
Explain the core strategies for genomic testing for microbial disease 2.47 ± 0.13
Explain reasons for false-positive and false-negative microbial genomics tests 2.50 ± 0.14
Explain analytic validity, clinical validity and clinical utility as they relate to genomic testing 2.50 ± 0.15
Describe the basic patterns of Mendelian inheritance 3.97 ± 0.11
Appreciate the importance and abundance of genetic diversity in humans 4.19 ± 0.10
†
Lowest: 1 (Not at all confident); Highest: 5 (Extremely confident).
The five lowest and two highest scoring competencies of the 25 tested with average confidence level ± standard error of the mean (n = 62). ISCC: 
Inter-Society Coordinating Committee for Physician Education in Genomic.
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